优先选择全球或全国头部供应商;BONTAC® 全酶法 β-NMN 以 99.9% 纯度与 β 型活性为质量门槛。全球同类先进水平是立项的基本门槛。We prioritize globally or nationally leading suppliers; BONTAC® full-enzymatic β-NMN at 99.9% purity and active β-isomer is our quality baseline. Globally competitive performance is a baseline for product approval.
核对配方与原料 →Inspect formula & materials →
CORE · 单一成分 · NAD⁺ 日常支持CORE · single ingredient · everyday NAD⁺ support
高纯基础 NMNNMN Pure
每粒 500 mg BONTAC® 全酶法 β-NMN,99.9% 纯度;每瓶 120 粒、标示总量 60,000 mg。单一活性成分、剂量完整公开——成分、证据边界与批次报告,都可以继续往下核对。 500 mg BONTAC® full-enzymatic β-NMN per capsule at 99.9% purity; 120 capsules per bottle, 60,000 mg total labeled. One active, fully disclosed—ingredient, evidence boundaries, and batch records can all be checked below.
- 剂型Format
- 胃溶明胶胶囊(0 号)Gastric-soluble gelatin capsule (size 0)
- 每份用量Serving
- 1 粒(500 mg)1 capsule (500 mg)
- 每瓶份数Servings
- 120
- 单一活性成分Single active
- BONTAC® β-NMN · 99.9%
- 不含Free of
- TiO₂ · gluten · soy
- 产地Origin
- 中国香港 · cGMP 工厂Hong Kong · cGMP facility
以完整成本为基准,当前中国单瓶毛利率约 30%–35%;规模扩大后继续下压。成本、毛利与价格同步公开。Against fully loaded cost, the current China gross margin is about 30%–35%. As scale grows, we will keep lowering it. Costs, margins, and pricing remain open.
查看成本与定价 →View costs & pricing →围绕每个批次,公开原料 COA 与成品第三方检测;成本、供应链、资质与检测四类信息均可继续核对。未上线文件不编造预览。Each lot links raw-material COAs and finished-product third-party tests. Costs, suppliers, qualifications, and testing remain open to verification. Unpublished files are not faked with placeholders.
打开批次档案 →Open batch archive →产品目标Product purpose
把一味 NMN 做透:剂量透明、证据诚实、长期压低加价One ingredient, done thoroughly: transparent dose, honest evidence, lower markup over time
CORE 基础款面向 NAD⁺ 日常营养支持:不堆协同成分,把 500 mg 全酶法 β-NMN 的剂量、纯度与证据边界写清楚;持续迭代原料与批次公开,并压低加价率。若你需要多路径复方,可查看百吉复配 NMN——两条路径各有定位,互不贬低。This CORE formula supports everyday NAD⁺ nutrition without stacking synergists—500 mg full-enzymatic β-NMN with dose, purity, and evidence boundaries fully disclosed. We refine materials and batch transparency while lowering markup. For a multi-path complex, see NMN Ultimate Complex—both paths serve different needs without dismissing either.
应对日常疲倦与状态波动For everyday fatigue and energy dips
NMN围绕 NAD⁺ 前体与细胞能量路径Built around the NAD⁺ precursor path
NMN每日 1 粒、约 4 个月/瓶的稳定补充节奏One capsule daily; about four months per bottle
500 mg / day只要 NMN 标量、不要多成分协同时选本品;要多路径可看复配页Choose this for NMN dose alone; see the complex for multi-path support
NMN Complex ↗产品全貌Product at a glance
一种成分,剂量写满标签One active. Dose on the label.
单一 BONTAC® β-NMN 500 mg/粒,无隐藏复配;每瓶 120 粒、标示总量 60,000 mg。Single BONTAC® β-NMN at 500 mg per capsule, no proprietary blend; 120 capsules per bottle, 60,000 mg total labeled.

一条 NAD⁺ 前体路径One NAD⁺ precursor path
全酶法 β-NMN 经补救合成途径一步转化为 NAD⁺;不叠加甲基供体、线粒体或探索性协同层。Enzymatic β-NMN converts to NAD⁺ in one step on the salvage pathway; no methyl donor, mitochondrial, or exploratory synergy layers.
BONTAC® β-NMN · 99.9% · 全酶法
莱可福生产;检测档案口径 1 + 1(原料 COA + 成品第三方)。Made by LEKKERFOOD; testing archive 1 + 1 (raw COA + finished third-party test).
按中国单瓶价 ¥268 与标准每日 1 粒计算;可至 2 粒/日(1000 mg)上限。Based on China price ¥268 and one capsule daily; up to 2 capsules (1000 mg) as upper limit.
完整配方Complete formula
每日一粒,
单一成分,剂量清晰One capsule.
One active, dose disclosed.
仅一行活性成分:500 mg BONTAC® β-NMN;辅料与每日参考值一并写清,无隐藏复配。One active row: 500 mg BONTAC® β-NMN; excipients and %DV status shown, with no proprietary blend.
人体试验常用剂量落在此区间;本品 500 mg/粒可按需每日 1 粒或至多 2 粒(1000 mg),按研究水平添加而非象征性剂量。Human trials commonly use this range; at 500 mg/capsule you may take 1 daily or up to 2 (1000 mg)—dosed to studied levels, not token amounts.
把 NMN 一味做透:不与白藜芦醇、紫檀芪等常被一并营销的「NAD⁺ 复方」混配——这类协同的人体证据多数不足。We do one ingredient thoroughly—no resveratrol, pterostilbene, or other "NAD⁺ stack" actives whose combined human evidence is mostly insufficient.
500 mg × 120 份 = 每瓶标示总量 60,000 mg(电商常见「60000mg」口径)。500 mg × 120 servings = 60,000 mg per bottle (common "60000mg" listing figure).
配方理念Formula architecture
单一路径:NAD⁺ 前体一层Single path: one NAD⁺ precursor layer
不叠四层复方;只保留 NMN → NAD⁺ 这一条可在人体研究中核对的路径。No four-layer complex—only the NMN → NAD⁺ path verifiable in human research.
NMN 经 NMNAT 酶一步转化为 NAD⁺;人体 RCT 中血液 NAD⁺ 上升较一致。NMN converts to NAD⁺ in one step via NMNAT; blood NAD⁺ rises most consistently in human RCTs.
ANAD⁺ 指标变化不等于延寿或功能改善;荟萃分析对血糖、血脂、肌量终点多为阴性或不支持。A change in NAD⁺ is not lifespan or functional proof; meta-analyses are negative or non-supportive for glycemic, lipid, and muscle endpoints.
A短期人体研究耐受良好;EFSA 对 β-NMN 作为烟酰胺来源出具安全意见,新食品授权程序尚未完成。Short-term human studies show good tolerance; EFSA issued a safety opinion on β-NMN as a nicotinamide source—the Novel Food authorization is not yet complete.
B / REG成分档案Ingredient profiles
一种成分,
剂量与边界写清One active,
dose and boundaries disclosed
展开查看剂量依据、研究边界;进入 WIKI 阅读完整 NMN 资料。Open for dosage rationale and evidence limits; continue to the WIKI for the full NMN record.
01BONTAC® β-NMNNAD⁺ precursor · 99.9%单一活性成分Single active500 mgWIKI ↗+
NAD⁺ 的直接前体;本品仅含这一味活性成分——BONTAC® 全酶法 β 型,纯度 99.9%。A direct NAD⁺ precursor and the sole active in this formula—BONTAC® full-enzymatic β-isomer at 99.9% purity.
500 mg 位于人体试验常用区间 250–900 mg/日;每日 1 粒为标准用量,可至 2 粒(1000 mg)上限。不把动物剂量直接放大成人体承诺。500 mg sits within the common 250–900 mg/day human-study range; 1 capsule is standard, up to 2 (1000 mg) as upper limit. Animal doses are not converted into human promises.
血液 NAD⁺ 上升较一致,但不等于延寿;体能荟萃非显著、血糖血脂阴性、肌量不支持;整体抗衰人体证据仍稀缺。营销最响的方向,往往是证据最弱的方向。Blood NAD⁺ rises most consistently, but that is not lifespan proof; performance meta-analyses are non-significant, glycemic/lipid outcomes negative, muscle outcomes unsupported; clear human anti-aging evidence remains scarce.
科学证据Evidence ledger
不只列有利研究Not only favorable findings
人体试验、综述、监管意见和阴性结果分级公开;剂量与单方相关性写在上方成分档案;这里只列可核对的研究收据。Human trials, reviews, regulatory opinions, and negative results are graded separately. Dose relevance lives in the ingredient profile above; this section is the verifiable receipt list.
多中心双盲安慰剂对照试验(n=80):NMN 以剂量相关方式提升全血 NAD⁺。Multicenter double-blind placebo-controlled trial (n=80): NMN raised whole-blood NAD⁺ in a dose-related manner.
GeroScience · 2022 · PMID 36482258NMN 与体能表现:RCT 系统综述(10 项、n=437)——与体力/有氧改善非显著相关,耐受良好。NMN and physical performance: systematic review of RCTs (10 studies, n=437)—non-significant association with physical/aerobic improvement; well tolerated.
Cureus · 2024 · PMID 39221308RCT 系统综述与荟萃分析(n=342):短期 NMN 未显著改善空腹血糖、胰岛素、HbA1c 或血脂。Systematic review and meta-analysis (n=342): short-term NMN did not significantly improve fasting glucose, insulin, HbA1c, or lipids.
Current Diabetes Reports · 2024 · PMID 39531138骨骼肌质量与功能荟萃(10 项 RCT):现有证据不支持 NMN/NR 改善肌量、握力或步速。Meta-analysis of skeletal muscle outcomes (10 RCTs): current evidence does not support NMN/NR improving muscle mass, grip, or gait speed.
J Cachexia Sarcopenia Muscle · 2025 · PMID 40275690人体临床试验安全性与「抗衰」效应综述:NMN 耐受良好、能升高 NAD⁺,但明确的人体抗衰效应证据仍稀缺。Review of human trials on safety and "anti-aging" effects: NMN well tolerated and raises NAD⁺, but clear human anti-aging evidence remains scarce.
Advances in Nutrition · 2023 · PMID 37619764首次健康男性单次口服研究:至 500 mg NMN 耐受良好,未见显著临床不良发现。First single-dose study in healthy men: up to 500 mg NMN well tolerated without significant clinical findings.
Endocrine Journal · 2020 · PMID 31685720EFSA 新食品安全科学意见:β-NMN 在拟定条件下作为烟酰胺(维生素 B3)来源安全;新食品授权程序尚未完成。EFSA Novel Food safety opinion: β-NMN safe as a nicotinamide (vitamin B3) source under proposed conditions; authorization procedure not yet complete.
EFSA Journal · DOI 10.2903/j.efsa.2026.10007我们不主张What we do not claim
- 不把它写成疾病治疗方案或「抗衰老治疗」。It is not a disease treatment or "anti-aging therapy."
- 不承诺快速、可感知的效果。No promise of fast, felt effects.
- 不把 NAD⁺ 指标变化等同于延长寿命。A change in NAD⁺ is not proof of longer lifespan.
已知阴性与风险Negative and risk signals
- 体能荟萃:与体力/有氧改善非显著相关。Performance meta-analysis: non-significant association with physical/aerobic improvement.
- 代谢荟萃:血糖、血脂终点为阴性。Metabolic meta-analysis: negative for glycemic and lipid endpoints.
- 肌量荟萃:现有证据不支持功能改善。Muscle meta-analysis: current evidence does not support functional improvement.
我们还没有What we do not yet have
- 本品级长期、大样本人体终点研究——成分研究不能相加成产品结论。A long-term, large human-outcome trial for this specific product—ingredient studies do not add up to product proof.
- 孕期、哺乳期、儿童及长期合用的充分资料。Adequate evidence for pregnancy, nursing, children, or long-term combined use.
- 当前在售批次全部检测文件上线(历史批次 LB2240501 已公开,其余陆续补充)。All testing files for the current on-sale lot published (historical lot LB2240501 is public; others to follow).
孕期、哺乳期、儿童、正在用药或有健康状况者,使用前请咨询专业人士。成分剂量见上方「成分档案」。Seek professional advice before use during pregnancy, nursing, childhood, medication use, or an existing health condition. Dose details are in the ingredient profile above.
适用场景Everyday contexts
为长期 NAD⁺ 日常支持而设计Designed for long-term everyday NAD⁺ support
适合希望单一 NMN 标量、建立稳定补充习惯的成年人。For adults who want a single NMN dose and a steady supplementation routine.
主动养护Proactive upkeep注重长期健康、愿意稳定补充Focused on long-term health and steady use
高强度日常High-demand days长期高压、精力消耗大Sustained pressure and high energy demand
中老年养护Later adulthood希望单一成分、用法简单Prefer one active and a simple routine
怎么吃How to use
可以合理期待Reasonable expectation
不应期待Do not expect
建立稳定的每日补充习惯,观察耐受。Establish a consistent routine and observe tolerance.
一两次服用就出现明显体感。A dramatic effect after one or two servings.
把它视为长期营养支持的一部分,并结合睡眠、饮食和运动。Treat it as one part of long-term support alongside sleep, diet, and exercise.
替代专业建议,或保证特定健康结果。A replacement for professional advice or a guaranteed health outcome.
百吉会持续改进原料、批次公开、价格与信息体验。BIOGEEK will keep improving materials, batch disclosure, pricing, and information access.
每个版本一开始就是终点。That any version is final.
生产与批次资料Production & lot information
用包装批号,核对这一批产品Use the package lot code to check this production lot
本产品在莱可福香港 cGMP 工厂生产。检测档案口径 1 + 1:1 份 BONTAC 原料 COA + 1 份成品第三方检测。历史批次 LB2240501(2024.5.27)已公开;当前在售批次文件陆续上线,未上线不编造预览。Made by LEKKERFOOD in Hong Kong under cGMP. Testing archive 1 + 1: one BONTAC raw-material COA plus one finished-product third-party test. Historical lot LB2240501 (May 27, 2024) is published; current on-sale lot files are rolling out—unpublished files are not faked.
批号是识别这一批产品的号码,同时喷印在瓶身与纸盒上。检测档案按 1 + 1 组织:一份 BONTAC 原料 COA,加一份成品第三方检测。下方为历史批次已上线文件;原料 COA 与当前在售批次其余文件陆续公开,未上线不编造预览。The lot code identifies this production lot and is printed on both bottle and carton. The archive is 1 + 1: one BONTAC raw COA plus one finished third-party test. Cards below are published historical finished-test pages; the raw COA and remaining current-lot files will follow—unpublished files are not faked.
优质 · 透明 · 低价Quality · transparency · fair price
原料和成本,同时公开Open materials. Open cost structure.
以下为中国销售体系(京东口径)的单瓶成本结构与价格;美国售价 $59 为参考价。China-market (JD-style) unit economics below; U.S. price $59 is reference.
按包含生产、检测、物流仓储、包装运费、关税及平台费用的完整成本计算。规模扩大后继续下压。Calculated against the full disclosed cost base including production, testing, logistics, packaging, duties, and platform fees. Scale should lower this further.
一瓶 60,000 mg ≈ 约 5 瓶常规 12,000 mg 单方,参考总价约 ¥1000 起One bottle at 60,000 mg ≈ about five regular 12,000 mg singles, reference total from ~¥1000
中国销售体系价格;参考单方价格为同类产品抽样口径。多瓶阶梯未单独立档前,单价统一 ¥268。China-market pricing; comparable single figures use sampled category prices. Until quantity tiers are set, unit price stays ¥268.
八维自评Eight-dimension review
34.5 / 40,也公开少掉的 5.5 分34.5 / 40—with every deduction visible
百吉内部产品评估:配方、原料、价格、安全、透明、体验、信任与创新。BIOGEEK's internal review across formula, materials, value, safety, transparency, experience, trust, and innovation.
单方仅 NMN 一路径,人体终点仍依赖成分级证据;无复方协同研究层,也不等于更弱,只是评分口径不同。Single-ingredient NMN path only—human outcomes still rely on ingredient-level evidence; no complex synergy layer, not weaker by design, but scored differently.
1 + 1 批次结构已建立,历史 LB2240501 已公开;当前在售批次文件陆续上线,检索与聚合体验仍可改进。1 + 1 batch structure exists and lot LB2240501 is public; current on-sale lot files are rolling out and search/aggregation can improve.
单方产品线官网评价与长期公开记录仍在积累;电商历史反馈尚未完全聚合至本页。Site reviews and long-term public record for this single-ingredient line are still accumulating; marketplace history is not fully aggregated here yet.
单一 NMN 为成熟品类;创新主要在剂量透明、成本公开与诚实阴性证据叙事,尚无专属剂型、递送技术或产品级临床验证。Single NMN is a mature category; innovation here is mainly transparent dosing, open costing, and honest negative-evidence disclosure—no proprietary format, delivery tech, or product-level clinical validation yet.
用户评价Customer reviews
平台历史评价与官网已购评价,分别标明来源Marketplace history and verified site reviews, clearly sourced
电商历史评价保留平台、时间、规格与原始链接;官网评价仅向已完成订单开放。Marketplace reviews retain platform, date, SKU, and source link; site reviews are available only after a completed order.
来自中国电商平台的历史购买反馈。聚合展示时保留平台、购买时间、商品规格与原始链接,正负评价采用同一规则。Historical purchase feedback from China marketplaces. Aggregated entries retain platform, date, SKU, and source link, with one rule for praise and criticism.
评价入口绑定官网订单与具体规格;修改配方、剂型、包装、价格和信息公开方式的建议,会进入产品版本记录。The review entry is tied to a site order and SKU. Feedback on formula, format, packaging, pricing, and disclosure enters the product version record.
购买前Before buying
购买前常见问题Questions before you buy
怎么吃、有没有感觉、能不能抗衰、检测与合规地区,以及批次 1 + 1 怎么查。How to take it, what to expect, anti-aging claims, testing, regional compliance, and how to check the 1 + 1 batch archive.
吃 NMN 真的能抗衰老吗?Does NMN really slow aging?
目前没有充分的人体证据支持「抗衰老治疗」这类说法。可以确定的是:补 NMN 能提升血 NAD⁺(研究较一致),但那是化验指标,距离「活得更久更好」还有很长的因果链——2023 年综述明确指出人体抗衰效应证据仍稀缺。我们把它当作值得继续研究、但远未被人体证据证实的成分如实介绍。There isn't sufficient human evidence for "anti-aging therapy" claims. NMN raises blood NAD⁺ consistently in studies, but that lab marker is a long chain away from "living longer or better"—a 2023 review noted clear human anti-aging evidence remains scarce. We present it as worth continued study, not proven by human evidence.
多久才会有感觉?How long before I notice anything?
体感差异很大——很慢,甚至不一定有明显变化。血液 NAD⁺ 可在数周内上升,但「升了」不等于立刻有感觉。这是需要稳定长期服用的日常养护型产品,不是速效产品;不要期待立竿见影,也不要为追求体感自行加量。Subjective experience varies widely—slowly, and you may feel nothing obvious. Blood NAD⁺ can rise over weeks, but that doesn't equal an immediate sensation. This is for steady long-term upkeep, not a fast fix; don't increase the dose just to chase a feeling.
每天吃几粒,什么时候吃?How many capsules, and when?
多数成人每日 1 粒(500 mg);可按耐受至 2 粒(1000 mg),不建议更高。建议早或午餐前空腹,胃敏感者餐后。一瓶 120 粒约 4 个月。孕妇、哺乳期与儿童不建议使用。Most adults take 1 capsule (500 mg) daily; up to 2 (1000 mg) if well tolerated—not higher. Take before breakfast/lunch on empty stomach, or after meals if sensitive. One bottle lasts about four months. Not recommended during pregnancy, nursing, or childhood.
如何查看批次检测资料?How do I check batch testing?
在瓶身或纸盒找到批号,进入本页「批次」栏目核对。档案口径 1 + 1:一份 BONTAC 原料 COA + 一份成品第三方检测。历史批次 LB2240501 已公开;当前在售批次其余文件陆续上线,本页只展示已上线文件。Find the lot code on bottle or carton, then check the "Batches" section. Archive is 1 + 1: one BONTAC raw COA plus one finished third-party test. Historical lot LB2240501 is published; remaining current-lot files roll out—only published files appear here.
在中国 / 美国 / 欧洲能合法买到吗?Can I legally buy it in China / the US / Europe?
各地差别很大且一直在变。美国:FDA 2022 年曾裁定 NMN 不属膳食补充剂,2025 年又反转确认合法。中国大陆:NMN 未获批为保健食品或普通食品原料,跨境电商监管身份仍不明朗。欧盟:作为新食品尚在审批,EFSA 2026 年出具正面安全意见但未完成最终授权。使用前请确认所在地最新规定。Rules vary by region and keep changing. US: FDA reversed in 2025 to confirm NMN in dietary supplements. Mainland China: NMN is not approved as a health food or ordinary food ingredient; cross-border status remains unclear. EU: Novel Food review ongoing—EFSA issued a positive 2026 safety opinion but final authorization is incomplete. Confirm local rules before use.
和百吉复配 NMN 怎么选?How is this different from NMN Ultimate Complex?
本品 = 单一 500 mg NMN,适合只要标量、不要多成分协同的人。复配页 = 六种活性成分多路径,适合希望一条配方覆盖更多研究层的人。两条路径各有定位,互不贬低。This product = single 500 mg NMN for those who want dose alone. The complex = six actives and multiple paths for those who want one formula covering more research layers. Both paths serve different needs without dismissing either.

